TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design.

Kidney Int Rep

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Published: December 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10719596PMC
http://dx.doi.org/10.1016/j.ekir.2023.09.026DOI Listing

Publication Analysis

Top Keywords

trpc6 inhibitor
4
inhibitor 764198
4
764198 focal
4
focal segmental
4
segmental glomerulosclerosis
4
glomerulosclerosis phase
4
phase study
4
study design
4
trpc6
1
0
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!